Sabra Healthcare REIT Inc. (NASDAQ:SBRA)’s share price shot up 3% on Monday . The stock traded as high as $22.72 and last traded at $22.70, with a volume of 488,579 shares traded. The stock had previously closed at $22.04.

Several research firms recently weighed in on SBRA. Citigroup Inc. reduced their target price on Sabra Healthcare REIT from $24.00 to $22.00 and set a “neutral” rating on the stock in a research report on Thursday, July 7th. Canaccord Genuity reiterated a “hold” rating on shares of Sabra Healthcare REIT in a research report on Monday, May 2nd. Cantor Fitzgerald assumed coverage on Sabra Healthcare REIT in a research report on Thursday, June 23rd. They set a “buy” rating and a $28.00 target price on the stock. Zacks Investment Research upgraded Sabra Healthcare REIT from a “hold” rating to a “buy” rating and set a $23.00 price target for the company in a research note on Tuesday, July 5th. Finally, Mizuho lowered Sabra Healthcare REIT from a “buy” rating to a “neutral” rating and dropped their price target for the stock from $25.00 to $20.00 in a research note on Thursday, May 19th. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and five have given a buy rating to the stock. Sabra Healthcare REIT currently has a consensus rating of “Hold” and a consensus target price of $23.04.

The firm’s 50 day moving average price is $21.31 and its 200 day moving average price is $20.16. The firm has a market capitalization of $1.52 billion and a PE ratio of 43.79.

Sabra Healthcare REIT (NASDAQ:SBRA) last released its quarterly earnings data on Monday, May 2nd. The company reported $0.53 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.55 by $0.02. The company earned $62.60 million during the quarter, compared to analysts’ expectations of $57.50 million. During the same period last year, the firm posted $0.53 earnings per share. The company’s revenue was up 12.6% on a year-over-year basis. Equities research analysts forecast that Sabra Healthcare REIT Inc. will post $2.27 earnings per share for the current year.

In related news, Director Milton J. Walters sold 2,000 shares of Sabra Healthcare REIT stock in a transaction on Monday, June 6th. The stock was sold at an average price of $22.04, for a total transaction of $44,080.00. Following the completion of the sale, the director now owns 24,055 shares of the company’s stock, valued at $530,172.20. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.

Other hedge funds have recently added to or reduced their stakes in the company. Morgan Stanley boosted its stake in Sabra Healthcare REIT by 0.9% in the fourth quarter. Morgan Stanley now owns 55,899 shares of the company’s stock worth $1,131,000 after buying an additional 495 shares during the last quarter. New York State Common Retirement Fund boosted its stake in Sabra Healthcare REIT by 4.7% in the fourth quarter. New York State Common Retirement Fund now owns 82,967 shares of the company’s stock worth $1,678,000 after buying an additional 3,703 shares during the last quarter. Rhumbline Advisers boosted its stake in Sabra Healthcare REIT by 4.7% in the fourth quarter. Rhumbline Advisers now owns 102,430 shares of the company’s stock worth $2,072,000 after buying an additional 4,565 shares during the last quarter. California Public Employees Retirement System boosted its stake in Sabra Healthcare REIT by 1.3% in the fourth quarter. California Public Employees Retirement System now owns 109,400 shares of the company’s stock worth $2,213,000 after buying an additional 1,400 shares during the last quarter. Finally, California State Teachers Retirement System boosted its stake in Sabra Healthcare REIT by 1.6% in the fourth quarter. California State Teachers Retirement System now owns 120,686 shares of the company’s stock worth $2,441,000 after buying an additional 1,903 shares during the last quarter.

Sabra Health Care REIT, Inc is a real estate investment trust. The Company owns and invests in real estate serving the healthcare industry. The Company’s segment is investments in healthcare-related real estate properties. Its primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.